NCT03860298View on ClinicalTrials.gov

Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 17, 2019

Primary Completion Date

October 14, 2020

Study Completion Date

October 14, 2020

Conditions
Drug Resistant EpilepsyEpilepsy, Drug ResistantDrug Refractory EpilepsyEpilepsy, Drug RefractoryIntractable EpilepsyEpilepsy, IntractableMedication Resistant EpilepsyRefractory Epilepsy
Interventions
DEVICE

NaviFUS System

Using NaviFUS System treatment for 10 minutes in drug resistant epilepsy. The site of the NaviFUS exposure is where the future surgery will be removed. Patients will concomitant use of anti-epileptic drugs (AEDs).

Trial Locations (1)

11217

Taipei Veterans General Hospital, Taipei

Sponsors
All Listed Sponsors
collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

lead

NaviFUS Corporation

INDUSTRY

NCT03860298 - Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy | Biotech Hunter | Biotech Hunter